Cholera in Children and Vulnerable Populations

Children as the Highest-Risk Age Group
Malnutrition as a Major Risk Factor
Cholera in Pregnancy
HIV and Cholera
Elderly Patients
Refugee and Displacement Settings
Blood Type O as a Risk Factor
Managing SAM Combined with Cholera
Key Research
Connections
Featured Videos

Children as the Highest-Risk Age Group

Children — especially those under five years old — die from cholera faster than adults, and this is directly tied to basic physiology. A child's body simply has less fluid to lose before the loss becomes life-threatening.

Consider a 15-kilogram child (about 33 pounds — a typical 2-year-old). At 7% body water loss, the child is in "some dehydration." That 7% of 15 kg is just over 1 liter of fluid. A child with severe cholera can lose that volume in one to two hours of rice-water diarrhea. An adult weighing 70 kg has seven times the fluid reserve before reaching the same percentage deficit.

Children also have relatively greater surface-area-to-volume ratios, which means they lose fluid and heat faster per kilogram of body weight. Their cardiovascular compensatory mechanisms — the physiological tricks the body uses to maintain blood pressure and perfusion when blood volume drops — are less robust than in adults. A child's heart can only compensate for so long before it is overwhelmed.

The result is that children can progress from appearing well to cardiovascular collapse in as little as 2 to 3 hours of severe cholera diarrhea. This is not an exaggeration — cholera treatment center staff are trained to recognize that a child who looked "okay" an hour ago can be in irreversible shock by the time a caregiver has walked to a health center and back.

During major cholera outbreaks, children under 5 have historically had case fatality rates 2 to 5 times higher than adults in the same setting, even when access to basic care is theoretically available. The speed of deterioration means that by the time families recognize the severity and seek care, it may already be too late without very rapid assessment and treatment.

Malnutrition as a Major Risk Factor

Malnutrition and cholera form a devastating combination. Malnourished individuals — especially those with severe acute malnutrition (SAM), which is defined by weight-for-height more than 3 standard deviations below the norm or the presence of bilateral pitting edema — face dramatically worse outcomes from cholera than well-nourished people.

SAM roughly doubles the case fatality rate from cholera. The reasons are multiple and compounding:

Malnourished children have reduced gut barrier function — the intestinal wall is more permeable, allowing bacteria and toxins to translocate more easily
Immune function is severely impaired in SAM, meaning the body cannot mount an effective response to limit infection or recovery
Malnourished patients often have pre-existing electrolyte abnormalities (particularly low potassium and phosphate from inadequate intake) that cholera makes critically worse
Cardiac function may already be compromised in SAM (the heart muscle is affected by prolonged protein and micronutrient deficiency), reducing the reserve to handle hypovolemic stress
The edema of kwashiorkor (protein-deficiency malnutrition) masks dehydration — fluid can shift from the edematous compartments into the vascular space, masking how severe the fluid deficit actually is

The coexistence of SAM and cholera also creates a refeeding challenge. Standard cholera treatment involves fluid and electrolyte replacement, but the refeeding protocols for SAM require very careful, slow electrolyte repletion (especially potassium and phosphate) to avoid fatal refeeding syndrome. Doing both at once requires close clinical monitoring that strains even well-resourced treatment centers.

Cholera in Pregnancy

Cholera during pregnancy is a medical emergency that puts two lives at risk simultaneously. The physiological changes of pregnancy — increased blood volume, altered cardiovascular dynamics, and the massive fluid demands of the placenta — mean that cholera-related dehydration can reach dangerous levels faster and with more severe consequences for both mother and fetus.

The fetus depends entirely on placental blood flow for oxygen and nutrient delivery. When the mother's blood volume drops due to cholera-related dehydration, uteroplacental perfusion falls proportionally. Even moderate maternal dehydration reduces placental blood flow significantly. Severe maternal hypovolemic shock can cause complete cessation of placental perfusion, which rapidly leads to fetal asphyxia.

Pregnant women with cholera face elevated rates of:

Fetal distress — abnormal fetal heart rate patterns indicating hypoxia, often beginning within hours of the onset of maternal severe dehydration
Preterm labor — maternal dehydration, fever (if present), and metabolic acidosis can stimulate uterine contractions
Stillbirth — particularly when severe dehydration is not corrected within hours; case series from endemic areas report fetal death rates of 30–50% in maternal cholera with severe dehydration
Maternal death — pregnant women may not recognize or report dehydration signs as quickly, and the increased fluid demands of pregnancy mean they reach dangerous dehydration thresholds faster

Treatment is the same as for non-pregnant adults — aggressive oral or IV rehydration — but fetal monitoring should be initiated alongside maternal treatment whenever possible. Zinc supplementation, which is part of some cholera treatment protocols for children, is generally avoided in pregnancy due to uncertain effects on fetal development at therapeutic doses. Antibiotics (azithromycin) are considered safe in pregnancy if indicated.

HIV and Cholera

People living with HIV, particularly those with advanced disease and low CD4 counts, face distinctly worse outcomes from cholera than HIV-negative individuals. HIV affects cholera severity through several mechanisms.

The most significant is immune impairment. Secretory IgA antibodies in the gut lining are part of the normal immune defense against V. cholerae colonization and toxin binding. HIV progressively destroys CD4+ T cells, which are essential helpers for antibody production, including gut IgA. HIV-positive individuals with low CD4 counts have substantially reduced mucosal immunity and produce fewer anti-cholera antibodies in response to both infection and vaccination.

In HIV-positive individuals with advanced disease, cholera can cause bacteremia — bacteria in the bloodstream — at significantly higher rates than in immunocompetent patients. Normally, V. cholerae is an intestinal pathogen that does not invade tissues or enter the blood. But with a severely compromised gut barrier (which HIV also impairs) and reduced systemic immune clearance, the bacteria can cross into the bloodstream, causing septicemia. HIV-positive patients with cholera bacteremia have high mortality even with appropriate treatment.

HIV also affects treatment response. Antiretroviral drugs and antibiotics used for cholera (particularly doxycycline) can interact. Tetracycline-class antibiotics reduce absorption of some antiretrovirals. Azithromycin — the preferred single-dose antibiotic for cholera — is generally safe with antiretroviral regimens.

Additionally, HIV-positive patients are more likely to be malnourished, have lower baseline fluid reserves, and have concurrent infections that complicate management — creating a perfect storm of compounding vulnerabilities during a cholera outbreak.

Elderly Patients

Elderly people face cholera with reduced physiological reserves on multiple fronts. The cardiovascular changes of aging significantly impair the body's ability to compensate for the volume loss cholera causes.

In young healthy adults, when blood pressure starts to fall due to dehydration, the heart and blood vessels compensate aggressively: heart rate increases, blood vessels constrict to redirect blood to vital organs, and cardiac output adjusts. These compensatory mechanisms are driven by the autonomic nervous system — specifically the sympathetic ("fight or flight") response.

With aging, autonomic responsiveness declines significantly. The heart cannot increase its rate as quickly or as high in response to falling blood pressure (reduced chronotropic response). Blood vessel walls stiffen and cannot constrict as effectively or as rapidly. The kidneys, which in young adults can rapidly reduce urine output to preserve fluid when dehydration begins, lose this concentrating ability with age. The result is that elderly patients decompensate faster and at lower levels of dehydration than younger adults.

Pre-existing cardiovascular disease — common in elderly populations — worsens this further. A heart that is already working at reduced capacity due to heart failure, coronary artery disease, or arrhythmias has even less reserve to cope with the volume and electrolyte stresses of cholera.

Additionally, many elderly patients are on medications that worsen cholera outcomes: diuretics (which cause additional fluid and electrolyte losses), ACE inhibitors (which impair the kidney's ability to preserve sodium), and beta blockers (which prevent the compensatory tachycardia that partially maintains cardiac output during volume loss). Medication reconciliation is important when managing cholera in elderly patients — some medications may need to be temporarily held during the acute illness.

Refugee and Displacement Settings

The intersection of displacement and cholera is catastrophic and well documented. Nearly every major cholera outbreak of the past three decades has originated in or been amplified by refugee camps, internally displaced persons (IDP) settlements, or conflict-affected communities with collapsed water and sanitation infrastructure.

The specific conditions that make displacement settings explosive for cholera are:

Shared water sources: When hundreds or thousands of people draw water from a single contaminated river, well, or tanker truck, a single infected person's stool can reach the entire camp within days through water
Inadequate latrines: Open defecation near water sources, or pit latrines that overflow during rain, creates direct fecal contamination pathways
Crowding: Physical proximity enables both waterborne and food-contact transmission; cholera spreads through contaminated hands that prepare shared food
Malnutrition: Displacement is almost always associated with food insecurity; malnourished populations are more vulnerable to severe disease
Limited healthcare: Displacement settings rarely have adequate cholera treatment capacity — delayed treatment dramatically increases case fatality rates
Mobile population: People moving between camps and communities carry cholera to new areas that may lack any prior exposure or immunity

Mathematical modeling of cholera outbreak dynamics in displacement settings shows that a single case introduced into a camp can result in exponential growth to hundreds of cases within days if no water safety or treatment interventions are in place. Attack rates (the proportion of the population infected) in uncontrolled camp outbreaks can exceed 2–5% within the first week — far higher than in endemic community settings.

Blood Type O as a Risk Factor

One of the more surprising risk factors for severe cholera is a person's blood type. Individuals with blood type O are significantly more likely to develop severe cholera (the rice-water diarrhea, rapid dehydration form) than people with blood types A, B, or AB — even when exposed to the same amount of bacteria.

The evidence for this association is robust. Studies in Bangladesh, where cholera is endemic, found that blood type O individuals are 2 to 8 times more likely to develop severe cholera from El Tor biotype infection compared to non-O blood types. Blood type O constitutes about 45% of most populations, so this represents a very large proportion of the at-risk group.

The mechanism relates to the structure of cell surface antigens. ABO blood type antigens are present not just on red blood cells but also on the surface of intestinal epithelial cells — the very cells that cholera toxin targets. The O antigen (H antigen) appears to be the specific receptor that the El Tor biotype of V. cholerae binds to particularly effectively on intestinal cells.

People with blood type A, B, or AB have additional sugar molecules attached to their O (H) antigen — the A or B sugar additions — which physically block or alter the binding site and reduce how effectively cholera toxin binds to the cell surface. Blood type O individuals have the "bare" H antigen without these modifications, creating a more accessible binding site.

This explains a curious evolutionary observation: blood type O is relatively less common in regions of the world with historically high cholera burden (parts of South Asia and Africa have lower rates of blood type O than some other populations), suggesting centuries of selection pressure from cholera may have increased survival of non-O blood type individuals in these regions.

Managing SAM Combined with Cholera

Treating a child with both severe acute malnutrition and cholera simultaneously is one of the most challenging clinical situations in global health. Standard protocols for each condition, if applied independently, can cause harm when the two conditions coexist.

The rehydration dilemma: Standard cholera treatment involves rapid, large-volume fluid and electrolyte replacement. But in SAM, the heart, kidneys, and cells are fragile — overly rapid fluid infusion can cause fluid overload and heart failure (a condition called kwashiorkor-related cardiomyopathy makes the heart particularly vulnerable). WHO guidelines for SAM children recommend much more cautious rehydration rates and specifically warn against IV fluids unless there are signs of hypovolemic shock.

The WHO recommends a special oral rehydration solution for SAM called ReSoMal (Rehydration Solution for Malnutrition), which has lower sodium content than standard ORS (since malnourished children may have excess total body sodium despite low serum sodium) and added potassium and magnesium. However, in cholera, the massive sodium losses mean standard ORS may be more appropriate. Clinical judgment is needed case by case.

Zinc supplementation is recommended for all children with cholera (reduces duration and severity of diarrhea through effects on gut repair and immune function), and also forms part of the nutritional rehabilitation protocol for SAM. In SAM+cholera children, zinc (10 mg/day for infants under 6 months, 20 mg/day for older children for 10–14 days) should be given alongside rehydration.

Feeding needs to begin within 48 hours of stabilization — starvation worsens SAM outcomes — but must start with therapeutic feeding formulas (F-75 then F-100 per WHO SAM protocols) rather than full feeds, to avoid refeeding syndrome. The acute cholera phase requires pausing normal SAM nutritional rehabilitation until the child is stabilized and can tolerate enteral feeding without continuing massive diarrheal losses.

Key Research

Glass RI, et al. "Cholera in Africa: lessons on transmission and control for Latin America." Lancet. 1991;338(8770):791–795. PMID: 1681224
Glass RI, et al. "Predisposition for cholera of individuals with O blood group." Am J Epidemiol. 1985;121(6):791–796. PMID: 4014158
Harris JB, et al. "Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity." Infect Immun. 2005;73(11):7422–7427. PMID: 16239543
Bhattacharya MK, et al. "Severe acute malnutrition and cholera." Indian J Pediatr. 2003;70(3):251–254. PMID: 12793304
Victora CG, et al. "Association between breast-feeding and deaths due to pneumonia, diarrhoea, and other causes in Brazil." BMJ. 1989;299(6706):1033–1036. PMID: 2509073
Weill FX, et al. "Genomic history of the seventh pandemic of cholera in Africa." Science. 2017;358(6364):785–789. PMID: 29123067
Luque Fernandez MA, et al. "Cholera: The oldest epidemic diarrheal disease and its enduring relationship with poverty." J Infect Dis. 2019;220(Suppl 1):S1–S4. PMID: 31429885
Collins AE. "Vulnerability to coastal cholera ecology in Mozambique." Soc Sci Med. 2003;57(8):1557–1574. PMID: 12948580
Khatun F, et al. "Cholera in pregnant women and its outcomes in a high risk area." PLoS One. 2014;9(5):e97659. PMID: 24846105
Seas C, Gotuzzo E. "Vibrio cholerae." In: Mandell GL, et al., eds. Principles and Practice of Infectious Diseases. 8th ed. Philadelphia: Elsevier; 2015. (Reference standard textbook chapter)
Cravioto A, et al. "Association of Vibrio cholerae O1 El Tor with chronic diarrhea in malnourished children." Epidemiol Infect. 1992;108(2):309–316. PMID: 1572437

Connections

Back to Table of Contents